Sivik Global Healthcare LLC 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Sivik Global Healthcare LLC disclosed 38 US equity positions worth $223.6m in its Q2 2025 13F filing. The largest position was XBI at 9.3% of the reported book, followed by THC and HCA. Against the Q1 2025 filing, it opened 10 new positions, added to 17 and reduced 7 among the top 38 holdings.
What did Sivik Global Healthcare LLC own in Q2 2025? Top 38 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | XBI SPDR S&P BIOTECH ETF | 9.3% | $20.7m | 250,000 | 0% | held | |
| 2 | THC TENET HEALTHCARE | Healthcare | 6.7% | $15.0m | 85,000 | 21% | added |
| 3 | HCA HCA HEALTHCARE INC | Healthcare | 4.3% | $9.6m | 25,000 | 0% | held |
| 4 | MCK MCKESSON CORP | Healthcare | 4.3% | $9.5m | 13,000 | 18% | added |
| 5 | UHS UNIV HEALTH SVC | Healthcare | 4.3% | $9.5m | 52,500 | 62% | added |
| 6 | BSX BOSTON SCIENTIFIC CORPORATION | Healthcare | 3.8% | $8.6m | 80,000 | -20% | reduced |
| 7 | LLY ELI LILLY & CO | Healthcare | 3.8% | $8.6m | 11,000 | 22% | added |
| 8 | DHR DANAHER CORP | Healthcare | 3.5% | $7.9m | 40,000 | 14% | added |
| 9 | CAH CARDINAL HEALTH | Healthcare | 3.4% | $7.6m | 45,000 | -10% | reduced |
| 10 | SYK STRYKER CORP | Healthcare | 3.4% | $7.5m | 19,000 | 9% | added |
| 11 | COR CENCORA INC | Healthcare | 3.4% | $7.5m | 25,000 | 0% | held |
| 12 | ISRG INTUITIVE SURG | Healthcare | 3.2% | $7.1m | 13,000 | -7% | reduced |
| 13 | MDT MEDTRONIC INC | Healthcare | 3.1% | $7.0m | 80,000 | 7% | added |
| 14 | NVO NOVO-NORDISK A/S | Healthcare | 3.1% | $6.9m | 100,000 | 43% | added |
| 15 | HUM HUMANA INC. | Healthcare | 3.0% | $6.6m | 27,000 | 17% | added |
| 16 | WAT WATERS CORP | Healthcare | 2.8% | $6.3m | 18,000 | 6% | added |
| 17 | GILD GILEAD SCIENCES INC | Healthcare | 2.5% | $5.5m | 50,000 | 25% | added |
| 18 | CI CIGNA GROUP/THE | Healthcare | 2.4% | $5.5m | 16,500 | 32% | added |
| 19 | ABT ABBOTT LABS | Healthcare | 2.4% | $5.3m | 39,200 | -13% | reduced |
| 20 | A AGILENT TECHNOLOGIES INC | Healthcare | 2.4% | $5.3m | 45,000 | -10% | reduced |
| 21 | UNH UNITEDHEALTH GRP | Healthcare | 2.1% | $4.7m | 15,000 | 200% | added |
| 22 | SELECT MEDICAL HOLDINGS CORP | 2.0% | $4.6m | 300,000 | 50% | added | |
| 23 | DGX QUEST DIAGNOSTIC INC | Healthcare | 2.0% | $4.5m | 25,000 | – | new |
| 24 | RVTY REVVITY INC | Healthcare | 1.9% | $4.4m | 45,000 | – | new |
| 25 | BIO BIO-RAD LABS A | Healthcare | 1.9% | $4.3m | 18,000 | – | new |
| 26 | SNN SMITH & NEPHEW | Healthcare | 1.9% | $4.3m | 140,000 | 17% | added |
| 27 | RGEN REPLIGEN CORP | Healthcare | 1.7% | $3.7m | 30,000 | – | new |
| 28 | WST WEST PHARMACEUTICAL SERVICES INC | Healthcare | 1.5% | $3.3m | 15,000 | 20% | added |
| 29 | EHC ENCOMPASS HEALTH CORP | Healthcare | 1.4% | $3.1m | 25,000 | -52% | reduced |
| 30 | AVTR AVANTOR INC | Healthcare | 1.4% | $3.0m | 225,000 | 12% | added |
| 31 | ALGN ALIGN TECH INC | Healthcare | 1.3% | $2.8m | 15,000 | – | new |
| 32 | SGRY SURGERY PARTNERS INC | Healthcare | 1.2% | $2.8m | 125,000 | 0% | held |
| 33 | BAX BAXTER INTERNATIONAL INC. | Healthcare | 1.0% | $2.3m | 75,000 | -57% | reduced |
| 34 | COO COOPER COS INC | Healthcare | 1.0% | $2.1m | 30,000 | – | new |
| 35 | ALNY ALNYLAM PHARMACEUTICALS | Healthcare | 0.9% | $2.1m | 6,500 | – | new |
| 36 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 0.7% | $1.5m | 5,000 | – | new |
| 37 | ARGX ARGEN SE - ADR | Healthcare | 0.6% | $1.4m | 2,500 | – | new |
| 38 | INSP INSPIRE MEDICAL SYSTEMS INC | Healthcare | 0.6% | $1.3m | 10,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.